By Jessica Ingrid | Institutum Lex Feminae
The murder trial of Lindsay Clancy has placed postpartum mental illness before an American jury and a global audience. Clancy is accused of killing her three children in Massachusetts in January 2023.
Her defense maintains that she was experiencing postpartum psychosis and was not criminally responsible. Prosecutors contend that she understood the nature and wrongfulness of her actions.
As of 4 September 2026, the jury remains in deliberations. Clancy’s criminal responsibility is a question for the jury under Massachusetts law.
The trial has included sharply conflicting expert testimony concerning her mental condition, treatment and capacity at the time of the deaths.
This article does not attempt to resolve those disputed facts.
The case nevertheless raises a policy question that does not depend on the verdict: what happens when a woman enters the maternal mental-health system, but screening, diagnosis, treatment and continuing risk assessment do not operate as a coordinated structure?
Beyond Screening
Maternal mental health is a women’s-rights issue because pregnancy and childbirth expose women to distinct health risks that public systems must be equipped to recognize and treat.
The relevant right is not a guarantee that every adverse outcome will be prevented. It is access to appropriate care, continuity of treatment, informed decision-making and institutional accountability.
Massachusetts requires healthcare providers to offer screening for postpartum depression or major depressive disorder.
The state has developed screening standards, provider resources and referral initiatives. Its 2024 maternal-health legislation further expanded insurance coverage for postpartum-depression screening and other maternal services.
At the federal level, the Health Resources and Services Administration operates the National Maternal Mental Health Hotline, providing free and confidential support at all hours.
Among people who contacted the hotline for themselves between January and March 2026, 54 percent identified as postpartum and 24 percent as pregnant. Leading reasons for contact included feeling overwhelmed, relationship conflict, depression and anxiety.
These measures demonstrate that maternal mental health is formally recognized as a public-health priority. They do not establish whether women obtain timely clinical assessments, complete referrals, begin treatment or remain connected to care.
A screening records an activity. It does not measure an outcome.
Postpartum depression and postpartum psychosis also create different clinical and policy challenges. Postpartum depression is considerably more common. Postpartum psychosis is rarer, may develop rapidly and can involve hallucinations, delusions, severe confusion, mania or loss of contact with reality.
A system designed principally to identify depression may not reliably identify an evolving psychotic condition. Yet public reporting frequently combines multiple perinatal disorders or concentrates on depression-screening rates.
A jurisdiction can therefore report strong screening performance while remaining unable to answer basic questions about suspected psychosis, emergency assessments, treatment interruptions, psychiatric admissions or follow-up after discharge.
Measuring Effective Care
Maternal mental-health programs should follow the complete care pathway rather than report screening alone. Governments should be able to determine:
- How many women completed screening and screened positive.
- How many received a clinical assessment after referral.
- How long they waited for that assessment.
- How many began treatment and received follow-up.
- How frequently emergency intervention, hospitalization or treatment interruption occurred.
- What happened after discharge or transfer between providers.
These indicators can be published in aggregate while protecting patient privacy. Their purpose is not to replace clinical judgment with administrative targets. It is to identify where women are being lost between detection and treatment.
States should also report suspected postpartum psychosis and other acute psychiatric presentations separately from routine postpartum-depression screening. Confidential multidisciplinary reviews should examine maternal suicides and other catastrophic psychiatric outcomes for recurring problems involving access, communication and transitions between providers.
The Lindsay Clancy trial should not be used to claim that postpartum psychosis inevitably leads to violence. It does not. Nor does the publicly established evidence prove that medication caused the deaths or that every professional involved failed Clancy. Assertions of that kind may discourage women from seeking psychiatric care.
The defensible conclusion is narrower. The existence of screening laws, appointments and helplines does not demonstrate that a maternal mental-health system is effective. Effectiveness depends on whether warning signs are recognized, referrals become treatment, providers coordinate care and women remain supported after the first intervention.
A verdict can determine Lindsay Clancy’s criminal responsibility. It cannot determine whether America’s maternal mental-health infrastructure is functioning as intended.
That requires a separate inquiry grounded in measurable outcomes. Until governments can show what happens after screening, high screening rates will describe institutional activity rather than effective protection.
